Prioritising research topics identified by end-users for a successful and rapid uptake of new tuberculosis treatment regimens

European Respiratory Journal 2026

View at publisher
Authors: Alessandra Bellavia, Tsion Asfaw Refera, Lia D’Ambrosio, Rosella Centis, Onno W. Akkerman, Fatma Alyaquobi, Erlina Burhan, Anh Tuan Dinh‐Xuan, Irina Felker, José-María García-García, Gina Gualano, Ananthu James
+24 more Syed Karam Shah, Yousra Kherabi, Yang Li, Christian Lienhardt, Rifat Mahfuza, Marcela Muñóz-Torrico, C. W. M. Ong, Ramesh Panchagnula, Alberto Piubello, Daria Podlekareva, Emanuele Pontali, Molebogeng Xheedha Rangaka, Najiha Rasheed, Adrián Rendón, Denise Rossato Silva, Muhammad Abdul Hamid Selim, Barbara Seaworth, Marina Tadolini, Simon Tiberi, Simone Villa, Cary Amiel Villanueva, Mario C. Raviglione, Giovanni Battista Migliori, for the Global Tuberculosis Network and FAST-TB End-User Survey Group
DOI: 10.1183/13993003.00989-2026
Cited by: 1
References: 9

Abstract

Extract With 10.7 million cases and 1.2 million deaths estimated for 2024, tuberculosis (TB) is a clinical and public health priority [1]. With the emergence of new drugs [2], the importance of improving existing treatment regimens has gained wide interest within the scientific community worldwide [3, 4].

Fields of Study & Subjects

Tuberculosis Research and Epidemiology Inhalation and Respiratory Drug Delivery Immune responses and vaccinations

Publication details

Journal / source
European Respiratory Journal
Publisher
European Respiratory Society (ERS)
Volume
68
Issue
3
Pages
2600989–2600989
Publication date
30 July 2026
Language
EN